Abstract:The ability to rapidly detect apoptotic cells and accurately evaluate therapeutic effects is significant in cancer research. To address this target, a biocompatible, ultrasensitive photoelectrochemical (PEC) cytosensing platform was developed based on electrochemically reduced graphene (EG)/ZnIn2S4 cosensitized TiO2 coupled with specific recognition between apoptotic cells and phosphatidylserine-binding peptide (PSBP). In this strategy, the HL-60 cells were selected as a model and C005, nilotinib, and imatinib were selected as apoptosis inducers to show cytosensing performances. In particular, a TiO2 photoactive substrate was designed as hollow spheres to enhance the PEC performance. Graphene was electrodeposited on the hollow TiO2-modified electrode to accelerate electron transfer and increase conductivity, followed by in situ growth of ZnIn2S4 nanocrystals as photosensitizers via successive ionic layer adsorption and reaction method, forming a TiO2/EG/ZnIn2S4 cosensitized structure that was used as a PEC matrix to immobilize PSBP for the recognition of early apoptotic cells. The detection of apoptotic cells was based on steric hindrance originating from apoptotic cell capture to induce an obvious decrease in the photocurrent signal. The ultrahigh sensitivity of the cytosensor resulted from enhanced PEC performance, bioactivity, and high binding affinity between PSBP and apoptotic cells. Compared with other assays, incorporate toxic elements were avoided, such as Cd, Ru, and Te, which ensured normal cell growth and are appropriate for cell analysis. The designed PEC cytosensor showed a low detection limit of apoptotic cells (as low as three cells), a wide linear range from 1 × 103 to 5 × 107 cells/mL, and an accurate evaluation of therapeutic effects. It also exhibited good specificity, reproducibility, and stability.

An electrochemical-TUNEL method for sensitive detection of apoptotic cells.

Toward the early evaluation of therapeutic effects: an electrochemical platform for ultrasensitive detection of apoptotic cells.

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Peptide-Based Photoelectrochemical Cytosensor Using a Hollow-TiO2/EG/ZnIn2S4 Cosensitized Structure for Ultrasensitive Detection of Early Apoptotic Cells and Drug Evaluation.

Ultrasensitive Amperometric Cytosensor for Drug Evaluation with Monitoring Early Cell Apoptosis Based on Cu2O@PtPd Nanocomposite As Signal Amplified Label

An Annexin V-based Biosensor for Quantitatively Detecting Early Apoptotic Cells

A label-free electrochemiluminescence cytosensors for specific detection of early apoptosis.

Surface-Enhanced Raman Scattering-Fluorescence Dual-Mode Nanosensors for Quantitative Detection of Cytochrome c in Living Cells.

In Situ Label-Free and Sensitive Detection Assay for Cell Apoptosis Via Polyadenosine-Coralyne Fluorescence Enhancement Strategy

A Novel Strategy for Real-Time and in Situ Detection of Cytochrome C and Caspase-9 in Hela Cells During Apoptosis

Smart Plasmonic Nanorobot for Real-Time Monitoring Cytochrome C Release and Cell Acidification in Apoptosis During Electrostimulation

Fluorescence Activation Imaging Of Cytochrome C Released From Mitochondria Using Aptameric Nanosensor

Electrochemical approach to detect apoptosis.

Biocompatible conductive architecture with surface-confined probe for non-invasive electrochemical cytosensing

A Highly Sensitive Electrochemical Cytosensor Based on a Triple Signal Amplification Strategy Using Both Nanozyme and DNAzyme

Real-Time Cellular Cytochrome C Monitoring Through an Optical Microfiber: Enabled by a Silver-Decorated Graphene Nanointerface

Portable and Visual Detection of Cytochrome c with Graphene Quantum Dots–Filter Paper Composite

Microfluidic chip integrated with flexible PDMS-based electrochemical cytosensor for dynamic analysis of drug-induced apoptosis on HeLa cells.

An Effective DNA-based Electrochemical Switch for Reagentless Detection of Living Cells.

Signal amplification cytosensor for evaluation of drug-induced cancer cell apoptosis.

A Fluorescent Turn on Nanoprobe for Simultaneous Visualization of Dual-Targets Involved in Cell Apoptosis and Drug Screening in Living Cells